Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience:
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Lund
1966
|
Schriftenreihe: | Acta medica Scandinavica. Suppl.
448=Vol. 180. Suppl. 448. |
Beschreibung: | Text engl. |
Beschreibung: | 46 S.m.Tab. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV007171166 | ||
003 | DE-604 | ||
005 | 20140319 | ||
007 | t | ||
008 | 930421s1966 |||| 00||| eng d | ||
035 | |a (OCoLC)185756433 | ||
035 | |a (DE-599)BVBBV007171166 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-188 | ||
100 | 1 | |a Nilsson, Inga M. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience |c Inga Marie Nilsson ; Lennart Andersson ; Sven Erik Björkman* |
264 | 1 | |a Lund |c 1966 | |
264 | 3 | |b Berling | |
300 | |a 46 S.m.Tab. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Acta medica Scandinavica. Suppl. |v 448=Vol. 180. Suppl. 448. | |
500 | |a Text engl. | ||
700 | 1 | |a Andersson, Lennart |e Verfasser |4 aut | |
700 | 1 | |a Björkman, Sven Erik |e Verfasser |4 aut | |
830 | 0 | |a Acta medica Scandinavica. Suppl. |v 448=Vol. 180. Suppl. 448. |w (DE-604)BV000000651 |9 448 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-004581751 |
Datensatz im Suchindex
_version_ | 1804121372249554944 |
---|---|
any_adam_object | |
author | Nilsson, Inga M. Andersson, Lennart Björkman, Sven Erik |
author_facet | Nilsson, Inga M. Andersson, Lennart Björkman, Sven Erik |
author_role | aut aut aut |
author_sort | Nilsson, Inga M. |
author_variant | i m n im imn l a la s e b se seb |
building | Verbundindex |
bvnumber | BV007171166 |
ctrlnum | (OCoLC)185756433 (DE-599)BVBBV007171166 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01079nam a2200313 cb4500</leader><controlfield tag="001">BV007171166</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20140319 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1966 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)185756433</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007171166</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nilsson, Inga M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience</subfield><subfield code="c">Inga Marie Nilsson ; Lennart Andersson ; Sven Erik Björkman*</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Lund</subfield><subfield code="c">1966</subfield></datafield><datafield tag="264" ind1=" " ind2="3"><subfield code="b">Berling</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">46 S.m.Tab.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Acta medica Scandinavica. Suppl.</subfield><subfield code="v">448=Vol. 180. Suppl. 448.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Text engl.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andersson, Lennart</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Björkman, Sven Erik</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Acta medica Scandinavica. Suppl.</subfield><subfield code="v">448=Vol. 180. Suppl. 448.</subfield><subfield code="w">(DE-604)BV000000651</subfield><subfield code="9">448</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004581751</subfield></datafield></record></collection> |
id | DE-604.BV007171166 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T16:56:56Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004581751 |
oclc_num | 185756433 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-188 |
owner_facet | DE-355 DE-BY-UBR DE-188 |
physical | 46 S.m.Tab. |
publishDate | 1966 |
publishDateSearch | 1966 |
publishDateSort | 1966 |
record_format | marc |
series | Acta medica Scandinavica. Suppl. |
series2 | Acta medica Scandinavica. Suppl. |
spelling | Nilsson, Inga M. Verfasser aut Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience Inga Marie Nilsson ; Lennart Andersson ; Sven Erik Björkman* Lund 1966 Berling 46 S.m.Tab. txt rdacontent n rdamedia nc rdacarrier Acta medica Scandinavica. Suppl. 448=Vol. 180. Suppl. 448. Text engl. Andersson, Lennart Verfasser aut Björkman, Sven Erik Verfasser aut Acta medica Scandinavica. Suppl. 448=Vol. 180. Suppl. 448. (DE-604)BV000000651 448 |
spellingShingle | Nilsson, Inga M. Andersson, Lennart Björkman, Sven Erik Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience Acta medica Scandinavica. Suppl. |
title | Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience |
title_auth | Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience |
title_exact_search | Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience |
title_full | Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience Inga Marie Nilsson ; Lennart Andersson ; Sven Erik Björkman* |
title_fullStr | Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience Inga Marie Nilsson ; Lennart Andersson ; Sven Erik Björkman* |
title_full_unstemmed | Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience Inga Marie Nilsson ; Lennart Andersson ; Sven Erik Björkman* |
title_short | Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience |
title_sort | epsilon aminocaproic acid e aca as a therapeutic agent based on 5 year s clinical experience |
volume_link | (DE-604)BV000000651 |
work_keys_str_mv | AT nilssoningam epsilonaminocaproicacideacaasatherapeuticagentbasedon5yearsclinicalexperience AT anderssonlennart epsilonaminocaproicacideacaasatherapeuticagentbasedon5yearsclinicalexperience AT bjorkmansvenerik epsilonaminocaproicacideacaasatherapeuticagentbasedon5yearsclinicalexperience |